Net earnings per share for the last 12 months: MetaVia (MTVA)

Graphic logo of MetaVia, Inc. (MTVA)

Venture capital expectations in the preclinical stage drive the dynamics of MetaVia Inc (MTVA), as confirmed by the current annual net income per share, where the actual level equals -4.05. The issuer aims to capture the metabolism and obesity therapy niche through the development of dual agonists. The attraction of leading scientists is ensured by stock options and the freedom to research treatments for neurodegeneration.

MTVA (MetaVia, Inc.) Net earnings per share for the last four quarters history from 11/30/2024 to 11/11/2026

Analytical breakdowns for MetaVia Inc. (MTVA)

- stock price and consensus target price:
Stock Price MetaVia, Inc.|MTVA - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Valuation MetaVia Inc.|MTVA - Total Company Value
- balance sheet net asset value indicators:
Book Value per Share MetaVia|MTVA - Book Valuation of Business|Market Capitalization to Book Value Ratio metaviatx.com|MTVA - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio MetaVia Inc|MTVA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital MetaVia, Inc.|MTVA - Company Total Debt Obligations|Debt to Book Capitalization Ratio MetaVia Inc.|MTVA - Company Long-Term Indebtedness|Company Short-Term Debts MetaVia|Quick Liquidity metaviatx.com
- net income and valuation multiples indicators:
MTVA - Net Income|Future Profit MetaVia Inc|MTVA - Market Price to Net Income Ratio|Projected Price to Earnings MetaVia, Inc.|MTVA - Price/Earnings to Growth Ratio|EV/EBITDA Multiple MetaVia Inc.|MTVA - Operating profit EBITDA|Earnings per share for the last twelve months MetaVia|MTVA - Earnings per share for the last 12 months|Quarterly EPS earnings growth metaviatx.com|MTVA - Earnings per share growth rate in current year|Expected earnings per share growth for next year MetaVia Inc
Fundamental company analysis:MTVA - metaviatx.com
Flagship merchandise of MetaVia Inc.

Investors use this indicator to assess the real return on each share of capital. The metric is calculated by dividing the total annual net income by the total number of shares. Analyzing the net earnings per share over the last four quarters can reveal hidden accounting anomalies. For MetaVia Inc (MTVA), such fluctuations often reflect the costs of joint dementia therapy development with clinics. The stability of the line confirms the effectiveness of investments in cognitive research.

Direct competitors

Biogen Inc. - Net earnings per share (EPS TTM)|NBIX - Net earnings per share (EPS TTM)|RGC (Regencell Bioscience Holdings Limited) - Net earnings per share for the last 12 months|AXSM (Axsome) - Earnings per share for the last twelve months|ACAD (ACADIA Pharmaceuticals Inc) - Net earnings per share (EPS TTM)|Xenon Corp (XENE) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) VKTX|Net earnings per share (EPS TTM) supernus.com (SUPN)|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year DNLI|Harmony Pharma - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Biohaven Corp BHVN|Amylyx Pharmaceuticals (AMLX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months TRVI|PRAX (Praxis Precision Medicines, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Anavex (AVXL)|Earnings per share for the last twelve months CeriBell Corp (CBLL)|Net earnings per share for the last 12 months Prothena Biosciences PRTA|Alector - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ANNX (annexonbio.com)|OMER: Net earnings per share for the last 12 months|NGNE: Earnings per share for the last twelve months|ACIU: Net earnings per share (EPS TTM)|Voyager Corp (VYGR) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Neumora Therapeutics|Earnings per share for the last 12 months SCLX (scilexholding.com)|Net earnings per share (EPS TTM) TVGN|ACOG - Net earnings per one share for the last twelve months|Cognition Therapeutics - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Inhibikase Pharma IKT|SAVA - Earnings per share for the last twelve months|Earnings per share for the trailing year ASRT (Assertio Holdings, Inc.)|coyatherapeutics.com (COYA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Vistagen (VTGN)|Earnings per share for the last twelve months Ovid Therapeutics Inc|Net earnings per share for the last 12 months Acumen Pharmaceuticals, Inc (ABOS)|Net earnings per share (EPS TTM) CRVO|ATHE - Net earnings per one share for the last twelve months|Clene - Net earnings per share for the last 12 months|Earnings per share for the last four quarters PEPG (PepGen Inc)|Jupiter Neurosciences Inc - Net earnings per share (EPS TTM)|RLMD - Net earnings per share (EPS TTM)|ANVS (Annovis Bio, Inc.) - Net earnings per share for the last 12 months|GRCE (Grace Therapeutics) - Earnings per share for the last twelve months|AIFF (Firefly Neuroscience) - Net earnings per share (EPS TTM)|ANEW Medical, Inc. (KLTO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) NRSN|Net earnings per share (EPS TTM) Reviva Pharmaceuticals, Inc. (RVPH)|NeurAxis, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year HSDT|Passage Bio Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Neuphoria Therapeutics Inc. NEUP|Minerva Neurosciences Corp (NERV) - Earnings per share for the last twelve months|Earnings per share for the last 12 months ATHA|ADXN (Addex Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Alzamend (ALZN)|Earnings per share for the last twelve months Cyclerion Therapeutics (CYCN)|Net earnings per share for the last 12 months protagenic.com PTIX|Pasithea Therapeutics Corp. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CRGT (Cortigent Inc)|ATXI: Net earnings per share for the last 12 months|BCLI: Earnings per share for the last twelve months|CARA: Net earnings per share (EPS TTM)|Chromocell Therapeutics Corp (CHRO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Eliem Therapeutics, Inc.|Earnings per share for the last 12 months ITCI (Intra-Cellular)|Net earnings per share (EPS TTM) LBPH|MRNS - Net earnings per one share for the last twelve months|NKGen Biotech - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) NeuroBo Pharmaceuticals Inc NRBO|SAGE - Earnings per share for the last twelve months|Earnings per share for the trailing year SNPX (Synaptogenix, Inc)|Trevena, Inc. (TRVN) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Vigil Neuroscience, Inc. (VIGL)|Earnings per share for the last twelve months Anew Medical|Net earnings per share for the last 12 months Cerevel Therapeutics Inc (CERE)